Dwyer, Karen M. http://orcid.org/0000-0002-4376-9720
Kishore, Bellamkonda K. http://orcid.org/0000-0001-8232-9827
Robson, Simon C. http://orcid.org/0000-0001-6374-0194
Article History
Accepted: 1 May 2020
First Online: 8 July 2020
Competing interests
: K.M.D. has no conflicts to declare. S.C.R. has had grant support from Tizona for development and characterization of antibodies to CD39. B.K.K. received research grant support and collaborated with AstraZeneca, and has United States patents issued for the use of P2Y2 and P2Y12 antagonists for the treatment of nephrogenic diabetes insipidus and other diseases.